Cargando…
Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target
Cytochrome P450 monooxygenases (CYPs/P450s) are heme-thiolate proteins whose role as a drug target against pathogenic microbes has been explored because of their stereo- and regio-specific oxidation activity. We aimed to assess the CYP53 family's role as a common alternative drug target against...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164535/ https://www.ncbi.nlm.nih.gov/pubmed/25222113 http://dx.doi.org/10.1371/journal.pone.0107209 |
_version_ | 1782334968738873344 |
---|---|
author | Jawallapersand, Poojah Mashele, Samson Sitheni Kovačič, Lidija Stojan, Jure Komel, Radovan Pakala, Suresh Babu Kraševec, Nada Syed, Khajamohiddin |
author_facet | Jawallapersand, Poojah Mashele, Samson Sitheni Kovačič, Lidija Stojan, Jure Komel, Radovan Pakala, Suresh Babu Kraševec, Nada Syed, Khajamohiddin |
author_sort | Jawallapersand, Poojah |
collection | PubMed |
description | Cytochrome P450 monooxygenases (CYPs/P450s) are heme-thiolate proteins whose role as a drug target against pathogenic microbes has been explored because of their stereo- and regio-specific oxidation activity. We aimed to assess the CYP53 family's role as a common alternative drug target against animal (including human) and plant pathogenic fungi and its role in fungal-mediated wood degradation. Genome-wide analysis of fungal species revealed the presence of CYP53 members in ascomycetes and basidiomycetes. Basidiomycetes had a higher number of CYP53 members in their genomes than ascomycetes. Only two CYP53 subfamilies were found in ascomycetes and six subfamilies in basidiomycetes, suggesting that during the divergence of phyla ascomycetes lost CYP53 P450s. According to phylogenetic and gene-structure analysis, enrichment of CYP53 P450s in basidiomycetes occurred due to the extensive duplication of CYP53 P450s in their genomes. Numerous amino acids (103) were found to be conserved in the ascomycetes CYP53 P450s, against only seven in basidiomycetes CYP53 P450s. 3D-modelling and active-site cavity mapping data revealed that the ascomycetes CYP53 P450s have a highly conserved protein structure whereby 78% amino acids in the active-site cavity were found to be conserved. Because of this rigid nature of ascomycetes CYP53 P450s' active site cavity, any inhibitor directed against this P450 family can serve as a common anti-fungal drug target, particularly toward pathogenic ascomycetes. The dynamic nature of basidiomycetes CYP53 P450s at a gene and protein level indicates that these P450s are destined to acquire novel functions. Functional analysis of CYP53 P450s strongly supported our hypothesis that the ascomycetes CYP53 P450s ability is limited for detoxification of toxic molecules, whereas basidiomycetes CYP53 P450s play an additional role, i.e. involvement in degradation of wood and its derived components. This study is the first report on genome-wide comparative structural (gene and protein structure-level) and evolutionary analysis of a fungal P450 family. |
format | Online Article Text |
id | pubmed-4164535 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41645352014-09-19 Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target Jawallapersand, Poojah Mashele, Samson Sitheni Kovačič, Lidija Stojan, Jure Komel, Radovan Pakala, Suresh Babu Kraševec, Nada Syed, Khajamohiddin PLoS One Research Article Cytochrome P450 monooxygenases (CYPs/P450s) are heme-thiolate proteins whose role as a drug target against pathogenic microbes has been explored because of their stereo- and regio-specific oxidation activity. We aimed to assess the CYP53 family's role as a common alternative drug target against animal (including human) and plant pathogenic fungi and its role in fungal-mediated wood degradation. Genome-wide analysis of fungal species revealed the presence of CYP53 members in ascomycetes and basidiomycetes. Basidiomycetes had a higher number of CYP53 members in their genomes than ascomycetes. Only two CYP53 subfamilies were found in ascomycetes and six subfamilies in basidiomycetes, suggesting that during the divergence of phyla ascomycetes lost CYP53 P450s. According to phylogenetic and gene-structure analysis, enrichment of CYP53 P450s in basidiomycetes occurred due to the extensive duplication of CYP53 P450s in their genomes. Numerous amino acids (103) were found to be conserved in the ascomycetes CYP53 P450s, against only seven in basidiomycetes CYP53 P450s. 3D-modelling and active-site cavity mapping data revealed that the ascomycetes CYP53 P450s have a highly conserved protein structure whereby 78% amino acids in the active-site cavity were found to be conserved. Because of this rigid nature of ascomycetes CYP53 P450s' active site cavity, any inhibitor directed against this P450 family can serve as a common anti-fungal drug target, particularly toward pathogenic ascomycetes. The dynamic nature of basidiomycetes CYP53 P450s at a gene and protein level indicates that these P450s are destined to acquire novel functions. Functional analysis of CYP53 P450s strongly supported our hypothesis that the ascomycetes CYP53 P450s ability is limited for detoxification of toxic molecules, whereas basidiomycetes CYP53 P450s play an additional role, i.e. involvement in degradation of wood and its derived components. This study is the first report on genome-wide comparative structural (gene and protein structure-level) and evolutionary analysis of a fungal P450 family. Public Library of Science 2014-09-15 /pmc/articles/PMC4164535/ /pubmed/25222113 http://dx.doi.org/10.1371/journal.pone.0107209 Text en © 2014 Jawallapersand et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Jawallapersand, Poojah Mashele, Samson Sitheni Kovačič, Lidija Stojan, Jure Komel, Radovan Pakala, Suresh Babu Kraševec, Nada Syed, Khajamohiddin Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target |
title | Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target |
title_full | Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target |
title_fullStr | Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target |
title_full_unstemmed | Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target |
title_short | Cytochrome P450 Monooxygenase CYP53 Family in Fungi: Comparative Structural and Evolutionary Analysis and Its Role as a Common Alternative Anti-Fungal Drug Target |
title_sort | cytochrome p450 monooxygenase cyp53 family in fungi: comparative structural and evolutionary analysis and its role as a common alternative anti-fungal drug target |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164535/ https://www.ncbi.nlm.nih.gov/pubmed/25222113 http://dx.doi.org/10.1371/journal.pone.0107209 |
work_keys_str_mv | AT jawallapersandpoojah cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget AT mashelesamsonsitheni cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget AT kovaciclidija cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget AT stojanjure cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget AT komelradovan cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget AT pakalasureshbabu cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget AT krasevecnada cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget AT syedkhajamohiddin cytochromep450monooxygenasecyp53familyinfungicomparativestructuralandevolutionaryanalysisanditsroleasacommonalternativeantifungaldrugtarget |